Rössner, Stephan

Who succeeds in maintaining weight loss? A conceptual review of factors associated with weight loss maintenance and weight regain

Elfhag, K., & Rössner, S. (2005) · Obesity Reviews

Eating Disorders and BehaviorsObesity, Physical Activity, Diet

Cited by 1,343

Effects of liraglutide in the treatment of obesity: A randomised, double-blind, placebo-controlled study

Astrup, A., Rössner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., Madsen, J., Rasmussen, M. F., & Lean, M. E. (2009) · The Lancet

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 1,163

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

James, W. P. T., Astrup, A., Finer, N., Hilsted, J., Kopelman, P., Rössner, S., Saris, W. H. M., & Gaal, L. F. V. (2000) · The Lancet

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 817

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

on behalf of the NN8022-1807 Investigators, Astrup, A., Carraro, R., Finer, N., Harper, A., Kunesova, M., Lean, M. E. J., Niskanen, L., Rasmussen, M. F., Rissanen, A., et al. (2012) · International Journal of Obesity

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 757

Weight Loss, Weight Maintenance, and Improved Cardiovascular Risk Factors after 2 Years Treatment with Orlistat for Obesity

Rössner, S., Sjöström, L., Noack, R., Meinders, A. E., Noseda, G., & Study, O. B. O. T. E. O. O. (2000) · Obesity Research

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 476

Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults

on behalf of the NN8022-1807 Investigators, Lean, M. E. J., Carraro, R., Finer, N., Hartvig, H., Lindegaard, M. L., Rössner, S., Van Gaal, L., & Astrup, A. (2014) · International Journal of Obesity

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 210

Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study.

Van Gaal, L. F., Scheen, A. J., Rissanen, A. M., Rössner, S., Hanotin, C., & Ziegler, O. (2008) · European Heart Journal

Pharmacology and Obesity TreatmentCannabis and Cannabinoid Research

Cited by 156

Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo‐controlled trial

Zelissen, P. M. J., Stenlof, K., Lean, M. E. J., Fogteloo, J., Keulen, E. T. P., Wilding, J., Finer, N., Rössner, S., Lawrence, E., Fletcher, C., et al. (2005) · Diabetes, Obesity and Metabolism

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 144

Intake of sweet foods and counts of cariogenic microorganisms in obese and normal-weight women.

Barkeling, B., Andersson, I., Lindroos, A., Birkhed, D., & Rössner, S. (2001) · European Journal of Clinical Nutrition

Oral microbiology and periodontitis researchDental Health and Care Utilization

Cited by 23